Stocks Gaining Momentum: Landec Corp. (NASDAQ:LNDC), Rubicon Minerals Corporation (NYSEMKT:RBY), NCI Building Systems Inc. (NYSE:NCS), Xencor (NASDAQ:XNCR), Celestica Inc. (NYSE:CLS)


Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, January 7, 2015 at 8 a.m. Pacific time to discuss its results for the second quarter fiscal year 2015. Financial results will be reported for the 2015 fiscal second quarter ended November 30, 2014 after market close on January 6, 2015. Landec Corp. (NASDAQ:LNDC) in last trading activity moved down -11.44% to close at $13.00. Company weekly performance is -4.13% while its quarterly performance stands at 3.75%. Landec Corp. (NASDAQ:LNDC) is -11.74% away from its 52 week high.

On December 18, Rubicon Minerals Corporation (NYSEMKT:RBY) announced that construction of its Ontario-based Phoenix gold project is on schedule, with initial production expected to take place in mid-2015. The project remains well funded. On last trading day Rubicon Minerals Corporation (NYSEMKT:RBY) moved down -17.38% to close at $0.87. Its volatility for the week is 10.86% while volatility for the month is 8.99%. RBY’s EPS growth for past 5 years was 24.20%. Rubicon Minerals Corporation (NYSEMKT:RBY) monthly performance is -15.78%.

NCI Building Systems Inc (NYSE:NCS) EVP Todd R. Moore unloaded 20,000 shares of the stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $17.79, for a total value of $355,800.00. Following the sale, the executive vice president now directly owns 84,012 shares in the company, valued at approximately $1,494,573. On last trading day NCI Building Systems Inc. (NYSE:NCS) moved down -2.02% to close at $17.46. Its volatility for the week is 4.91% while volatility for the month is 3.90%. NCS’s sales growth for past 5 years was -5.80% and its EPS growth for past 5 years was -15.00%. NCI Building Systems Inc. (NYSE:NCS) monthly performance is -7.37%.

On December 18, Xencor, Inc. (NASDAQ:XNCR) announced that it has entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover novel biologic drug candidates for an undisclosed target by combining multiple Xencor XmAb® technologies, including bispecific and immune inhibitor technologies. Xencor, Inc. (NASDAQ:XNCR) has 0.10% insider ownership while its institutional ownership stands at 42.80%. In last trading activity company’s stock closed at $16.62.

Celestica Inc (NYSE:CLS) has a short ratio of 2.07. A high short ratio indicates that the market is overly pessimistic on the shares while a low short reflects mildly bearish overhang. The 1-month %change in short interest is 5.75%. Over the past 3-months, the short interest has registered a change of -4.64%. On Friday shares of Celestica Inc. (NYSE:CLS) closed at $11.45. Company’s sales growth for last 5 years was -5.50% and EPS growth for next 5 years is recorded as 10.01%.


Leave a Reply

Your email address will not be published. Required fields are marked *